AUTOIMMUNE AND INFLAMMATORY DISEASES BIOMARKERS

Authors

  • Monika Chopra Department of Biotechnology, Mata Gujri College, Fatehgarh Sahib-140406, Punjab, India.
  • Kulwinder Singh Punjabi University, Patiala-147001, Punjab.
  • Neelam Verma Punjabi University, Patiala-147001, Punjab.

DOI:

https://doi.org/10.7439/ijbar.v3i4.347

Abstract

One of the major challenges facing the healthcare industry is how to personalize, or tailor healthcare products and services to individuals' unique genetic and biomarker make-ups. Biomarkers are characteristics that can be objectively measured and evaluated. They provide information about normal or patho-physiological processes to detect or define disease progression or to predict or quantify therapeutic responses. Once these footprints have been identified and measured, they can then be used to personalize or tailor treatment plans, products and services to each individual's unique makeup and background. Biomarkers enable early diagnosis, guide molecularly targeted therapy and monitor the activity and therapeutic responses across these diseases. Development of new, predictive safety and efficacy biomarkers is expected to reduce the time and cost of drug development. This review summarizes the integration and use of biomarkers in drug development, regulation and clinical practice with special emphasis on autoimmune and inflammatory diseases biomarkers.

Downloads

Download data is not yet available.

Author Biographies

  • Monika Chopra, Department of Biotechnology, Mata Gujri College, Fatehgarh Sahib-140406, Punjab, India.
    Assitant Professor, Department of Biotechnology, Mata Gujri College, Fatehgarh Sahib-140406, Punjab, India.
  • Kulwinder Singh, Punjabi University, Patiala-147001, Punjab.
    Research Scholar, Department of Biotechnology
  • Neelam Verma, Punjabi University, Patiala-147001, Punjab.
    Professor, Department of Biotechnology

Downloads

Published

2012-05-01

Issue

Vol. 3 No. 4 (2012): Apr

Section

Review Article

License

Authors who publish with this journal agree to the following terms:

  • Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  • Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  • Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).

How to Cite

AUTOIMMUNE AND INFLAMMATORY DISEASES BIOMARKERS. (2012). International Journal of Biomedical and Advance Research, 3(4), 215-224. https://doi.org/10.7439/ijbar.v3i4.347
Crossref
Scopus
Google Scholar
Europe PMC